Actinium Pharmaceuticals, Inc. , a leader in the development of differentiated targeted radiotherapies, today announced compelling preclinical data for ATNM-400, a first-in-class Actinium-225 (AC-225) ...

The offseason is now in full swing, and teams are making big moves via trades and free agency. On the domestic side, there’s ...

Periodic maintenance is common too, but still inefficient and often based on time, not actual machine condition. That ...

Bayer is deploying GenAI tools at scale while many corporates struggle to find ROI on AI. The difference may lie in a 12-year ...

Tissue expansion, originally developed for super-resolution imaging, has become a foundation for expansion omics (ExO), a ...

Meet Guideline, a marketing intelligence platform that aggregates anonymized agency billing data to generate data-driven ...

Associate Professor of Art and Head of Digital Media at the University of Nevada, Reno, explores the relationship between ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.